Effects of Maternal Alpha Methyldopa Administration on Memory of Rat Offspring during Growing Age

Background: Alpha Methyldopa (AMD) is a well-known treatment for the pregnancy induced hypertension and commonly used in several countries. Indeed the possible effect of AMD on the behavioral activities of offspring, whom are exposed during fetus period, has not been studied. The present study evaluated the possible effect of maternal administration of AMD on the rat offspring memory in the growing age. Methods: This study was carried out in Isfahan Faculty Of Pharmacy in 2015. Pregnant wistar rats were injected 400 mg/kg AMD or saline every day from 14 to 21 pregnancy period, respective to their group (n=8). The spatial memory of male offspring (n=9) was evaluated one, two and three month after the birth in the object recognition task. Also two groups of adult animals (n=7) were daily administered 400 mg/kg AMD or saline one week prior to the memory evaluation. The discrimination (d2), recognition (R) and frequencies of exploration of new object (FB) in the T2 trials are used as the memory indicating factors. Results: Daily single dose of 400 mg/kg AMD to the mothers one week prior to the delivery significantly decreased the d2 index, R index and FB in two and three months offspring rats compare to the their respective control groups. Conclusion: The newborn rats exposed maternally to the AMD during the fetus period show cognitive impairments in the growing age. Indeed the rate of memory enhancement follows a slow pattern compare to the control offspring rats.

[1]  M. Rabbani,et al.  Acute and chronic tramadol administration impair spatial memory in rat , 2016, Research in pharmaceutical sciences.

[2]  M. Zarrindast,et al.  Scopolamine induced memory impairment; possible involvement of NMDA receptor mechanisms of dorsal hippocampus and/or septum , 2012, Behavioural Brain Research.

[3]  D. Csonka,et al.  The effects of α‐methyldopa on myometrial noradrenaline release and myometrial contractility in rat , 2007, Acta obstetricia et gynecologica Scandinavica.

[4]  F. J. van der Staay,et al.  Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors. , 2007, European journal of pharmacology.

[5]  A. Blokland,et al.  The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat , 2007, Psychopharmacology.

[6]  Jian Ding,et al.  Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms , 2005, Neuroscience Letters.

[7]  P. Ladewig,et al.  Clinical Handbook for Maternal Newborn Nursing & Women's Health Care , 2003 .

[8]  E. Podjarny,et al.  Effect of Methyldopa on Renal Function in Rats with L-NAME-Induced Hypertension in Pregnancy , 2001, Nephron.

[9]  A. Arnsten,et al.  Noradrenergic alpha-2 receptor agonists reverse working memory deficits induced by the anxiogenic drug, FG7142, in rats , 2000, Pharmacology Biochemistry and Behavior.

[10]  M. Buhot,et al.  Role of serotonin in memory impairment , 2000, Annals of medicine.

[11]  JaneR . Taylor,et al.  A role for norepinephrine in stress-induced cognitive deficits: α-1-adrenoceptor mediation in the prefrontal cortex , 1999, Biological Psychiatry.

[12]  F. Colpaert,et al.  α2-Adrenoceptor modulation of cortical acetylcholine release in vivo , 1999, Neuroscience.

[13]  S. Boehm,et al.  α2-adrenoreceptor-mediated inhibition of acetylcholine-induced noradrenaline release from rat sympathetic neurons: An action at voltage-gated Ca2+ channels , 1995, Neuroscience.

[14]  A. Bobik,et al.  alpha-Methyldopa metabolism in central serotonergic nerve terminals: effects on serotonin levels, synthesis and release. , 1989, European journal of pharmacology.

[15]  P. Goldman-Rakic,et al.  The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[16]  P. Timmermans,et al.  The hypotensive activity and side effects of methyldopa, clonidine, and guanfacine. , 1984, Hypertension.

[17]  Rick S. Blum,et al.  Impairment of memory function by antihypertensive medication. , 1983, Archives of general psychiatry.

[18]  K. Setchell,et al.  A study of the disposition of alpha-methyldopa in newborn infants following its administration to the mother for the treatment of hypertension during pregnancy. , 1979, British journal of clinical pharmacology.

[19]  E. Conway,et al.  Effect of α-methyldopa on dopaminergic transmission in the corpus striatum , 1978, Neuropharmacology.

[20]  L. Loizou,et al.  Uptake of monoamines into central neurones and the blood‐brain barrier in the infant rat , 1970, British journal of pharmacology.

[21]  S. Udenfriend,et al.  THE EFFECTS OF α-METHYL-DOPA AND α-METHYL-META-TYROSINE ON THE METABOLISM OF NOREPINEPHRINE AND SEROTONIN IN VIVO , 1961 .

[22]  I. González-Burgos,et al.  Serotonin/dopamine interaction in memory formation. , 2008, Progress in brain research.

[23]  T. Ohuchi,et al.  MECHANISM OF THE ANTIHYPERTENSIVE EFFECT OF ALPHA-METHYLDOPA. , 1964, Nature.